Insider Sale at Genpact: 2,326 Shares Disposed by Director Lindstrom

Rhea-AI Filing Summary

Carol Lindstrom, a director of Genpact Limited (ticker G), reported a sale of 2,326 common shares on 08/12/2025 at $43.17 per share. After the disposition she beneficially owned 21,185 shares directly. The filing is limited to a single non-derivative sale and shows no option or derivative activity.

Positive

• Continued direct ownership: Reporting person retains 21,185 common shares after the sale
• Clear disclosure: Transaction reported on Form 4 with sale details and post-transaction holdings

Negative

• Insider disposition: Sold 2,326 common shares at $43.17 per share
• No indication of a repurchase or offsetting acquisition in this filing

Insights

Financial Analyst

TL;DR: Small director sale; remaining direct holdings of 21,185 shares limit near-term financial impact.

The reported sale of 2,326 shares at $43.17 is a straightforward insider disposition disclosed on Form 4. From a financial perspective this transaction reduces the reporting person's stake but leaves a >20,000-share direct holding, suggesting the sale is not a complete divestiture. No derivative transactions or additional changes to beneficial ownership were reported, so the immediate valuation or control implications appear limited based solely on this filing.

Corporate Governance Expert

TL;DR: Routine Form 4 disclosure of a director sale; no red flags in the filing itself.

The Form 4 documents a single non-derivative sale coded as a disposition. The report lists the reporting person as a Director and indicates direct ownership after the transaction. The filing contains no indication of Rule 10b5-1 plan use, related-party transactions, or derivative activity. Based on the submission alone, governance procedures appear followed through the required disclosure, with no material governance concerns identified.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindstrom Carol

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/12/2025		S		2,326	D	$43.17	21,185	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Carol Lindstrom	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Genpact director Carol Lindstrom report on Form 4 (G)?

The Form 4 reports a sale of 2,326 common shares on 08/12/2025 at $43.17 per share and shows 21,185 shares beneficially owned after the transaction.

How many shares does Carol Lindstrom own after the reported transaction?

The filing shows 21,185 shares owned directly following the reported sale.

Was the transaction an acquisition or disposal in the Form 4 for G?

The transaction was a disposition (sale), coded as an insider sale on the Form 4.

Did the Form 4 disclose any derivative transactions for Genpact (G)?

No. Table II for derivative securities is empty; the filing contains only the non-derivative sale.

What role does the reporting person hold at Genpact according to the filing?

The reporting person, Carol Lindstrom, is identified as a Director of Genpact Limited.